PPd: C, 44.0; H, 3.69; N, 12.8%. Found: C, 43.4; H, 3.55; N,
Synthesis of [PdCl{C(O)Me}(L2-ꢀ2P,N)] 6b
12.7%. 31P{1H} NMR (161.8 MHz, CD2Cl2): δ 89.3 (s). 1H
Compound 4b (0.050 g, 0.11 mmol) was transferred in a NMR
tube fitted with a Young valve and dissolved in a minimum
amount of CD2Cl2. A CO pressure of approximately 20 psi was
applied and the NMR tube was shaken vigorously. After 2 h
31P{1H} NMR spectroscopy indicated a conversion of approx-
imately 40%. 31P{1H} NMR (161.8 MHz, CD2Cl2): δ 78.9 (s).
3
NMR (399.8 MHz, CD2Cl2): δ 8.73 (dd, 1H, JHH 5.2 Hz,
4JHH 0.8 Hz, H6), 8.11 (ddd, 1H, 3JHH 7.2 Hz, 4JHH 0.8 Hz, 5JHP
3
1.2 Hz, H4), 7.36 (dd, 1H, JHH 5.6, 7.2 Hz, H5), 7.35 (d, 1H,
3JHH 4.4 Hz, H2), 7.03 (ps. quin, 4H, Hα), 6.92 (d, 1H, 3JHH 4.4
3
Hz, H3), 6.49 (m, 4H, Hβ), 0.95 (d, 3H, JHP 3.6 Hz, Me).
13C{1H} NMR (100.5 MHz, CD2Cl2) δ 154.2 (d, 2JCP 20 Hz, C8),
143.0 (s, C6), 132.3 (s, C4), 124.8 (d, 2JCP 7 Hz, C2), 124.0 (d, 2JCP
1H NMR (399.8 MHz, CD2Cl2): δ 8.53 (bd, 1H, JHH 4.8 Hz,
3
H6), 8.12 (m, 1H, H4), 7.40 (m, 1H, H5), 7.37 (m, 1H, H3), 7.05
8 Hz, Cα), 120.7 (d, 2JCP 7 Hz, C9), 119.6 (s, C5), 115.6 (d, 3JCP
Hz, Cβ), 111.9 (d, 2JCP 3 Hz, C3), Ϫ4.6 (d, 2JCP 5 Hz, Me).
8
3
(ps. quin, 4H, Hα), 6.90 (d, 1H, JHH 3.6 Hz, H2), 6.51 (m, 4H,
Hβ), 2.09 (s, 3H, Me). 13C{1H} NMR (100.5 MHz, CD2Cl2):
2
δ 219.3 (s, CO), 153.8 (d, JCP 18 Hz, C8), 142.9 (s, C6), 132.5
Synthesis of [PdMe(OTf)(L1-ꢀ2P,N)] 5a
(s, C4), 125.1 (d, 2JCP 8 Hz, C2), 124.0 (d, 2JCP 11 Hz, Cα), 121.0
3
3
(d, JCP 4 Hz, C9), 119.7 (s, C5), 115.8 (d, JCP 9 Hz, Cβ), 111.9
AgOTf (0.095 g, 0.37 mmol) was added to a dichloromethane
solution of 4a (0.170 g, 0.37 mmol). After 4 h stirring the sus-
pension was filtered to remove AgCl and the filtrate evaporated
to dryness. The resulting pale yellow powder was washed with
hexane and dried under reduced pressure. Yield: 0.192 g (91%).
Calc. for C21H18F3N2O3PPdS: C, 44.0; H, 3.17; N, 4.89%.
Found: C, 43.8; H, 3.16; N, 4.76%. 31P{1H} NMR (161.8 MHz,
(s, C3), 39.6 (d, JCP 32 Hz, Me). IR (CH2Cl2, cmϪ1): 1715
3
[s, ν(CO)].
Synthesis of [Pd{C(O)Me}(OTf)(L1-ꢀ2P,N)] 7a
Compound 5a (0.050 g, 0.087 mmol) was transferred into
a NMR tube fitted with a Young valve and dissolved in a
minimum amount of CD2Cl2. A CO pressure of approximately
20 psi was applied and the NMR tube was shaken vigorously.
After ∼5 min 31P{1H} NMR spectroscopy showed complete
conversion to 7a. The contents of the NMR tube were trans-
ferred into a Schlenk and a sample was taken to record the IR
spectrum. The solution was diluted with dichloromethane and
layered with hexane. Slow diffusion of hexane into the di-
chloromethane solution gave 7a as colourless crystals suitable
for X-ray diffraction studies. 31P{1H} NMR (161.8 MHz,
1
CD2Cl2): δ 84.6 (s). H NMR (399.8 MHz, CD2Cl2): δ 8.53
3
3
(d, 1H, JHH 5.6 Hz, H6), 8.07 (d, 1H, JHH 7.9 Hz, H4), 7.82–
7.46 (m, 6H, Hm, Hp), 7.54 (m, 4H, Ho), 7.32 (dd, 1H,
3
3
3JHH 5.6, 7.9 Hz, H5), 7.16 (dd, 1H, JHH 2.4 Hz, JHP 3.6 Hz,
3
3
H2), 6.86 (d, 1H, JHH 3.6 Hz, H3), 0.85 (d, 3H, JHP 1.6 Hz,
Me). 13C{1H} NMR (67.9 MHz, CD2Cl2): δ 154.8 (d, JCP
2
15 Hz, C8), 142.9 (s, C6), 133.7 (s, Cp), 133.3 (d, 2JCP 15 Hz, Co),
3
132.5 (s, Ci), 130.0 (d, JCP 12 Hz, Cm), 129.9 (s, C4), 126.4 (d,
2JCP 6 Hz, C2), 121.1 (d, JCP 6 Hz, C9), 119.1 (s, C5), 111.4 (s,
3
C3), Ϫ1.2 (d, JCP 4 Hz, Me). 19F{1H} NMR (376.2 MHz,
1
2
CD2Cl2): δ 65.5 (s). H NMR (399.8 MHz, CD2Cl2): δ 8.46 (d,
CD2Cl2): δ –78.9 (s).
3
3
1H, JHH 5.2 Hz, H6), 8.11 (d, 1H, JHH 8.0 Hz, H4), 7.71–7.64
(m, 6H, Ho, Hp), 7.57–7.52 (m, 4H, Hm), 7.30 (dd, 1H, 3JHH 5.2,
8.0 Hz, H5), 7.20 (dd, 1H, 3JHH 3.6 Hz, 3JHP 2.4 Hz, H2), 6.86 (d,
Synthesis of [PdMe(OTf)(L2-ꢀ2P,N)] 5b
3
4
1H, JHH 3.6 Hz, H3), 2.27 (d, 3H, JHP 1.2 Hz, Me). 13C{1H}
NMR (100.5 MHz, CD2Cl2): δ 220.1 (d, 2JCP 6 Hz, CO), 152.5
(d, 2JCP 14 Hz, C8), 142.8 (s, C6), 133.5 (d, 1JCP 2 Hz, Ci), 133.1
(d, 2JCP 15 Hz, Co), 132.6 (s, Cp), 129.9 (d, 3JCP 12 Hz, Cm), 127.6
(s, C4), 126.6 (d, 2JCP 6 Hz, C2), 121.6 (d, 3JCP 5 Hz, C9), 119.0 (s,
As for 5a using AgOTf (0.095 g, 0.37 mmol) and 4b (0.163 g,
0.37 mmol). Yield: 0.202 g, (98%). Calc. for C17H16F3N4O3-
PPdS: C, 37.1; H, 2.93; N, 10.2%. Found: C, 37.1; H, 2.98; N,
10.1%. 31P{1H} NMR (161.8 MHz, CD2Cl2): δ 90.1 (s). 1H
3
NMR (399.8 MHz, CD2Cl2): δ 8.48 (bd, 1H, JHH 5.6 Hz,
3
3
3
C5), 110.8 (s, C3), 36.5 (d, JCP 29 Hz, Me). 19F{1H} NMR
H6), 8.16 (dm, 1H, JHH 8.0 Hz, H4), 7.40 (dd, 1H, JHH 5.6,
3
3
(376.2 MHz, CD2Cl2): δ Ϫ78.7 (s). IR (CD2Cl2, cmϪ1): 1711 [s,
ν(CO)].
8.0 Hz, H5), 7.36 (ps. t, 1H, JHH 3.6 Hz, JHP 3.6 Hz, H2),
7.04 (ps. quin, 4H, Hα), 6.95 (d, 1H, 3JHH 3.6 Hz, H3), 6.54 (m,
4H, Hβ), 1.04 (s, 3H, Me). 13C{1H} NMR (100.5 MHz,
CD2Cl2): δ 153.8 (d, 2JCP 19 Hz, C8), 143.4 (s, C6), 133.1 (s, C4),
Synthesis of [Pd{C(O)Me}(OTf)(L2-ꢀ2P,N)] 7b
125.0 (d, 2JCP 6 Hz, C2), 124.2 (d, 2JCP 9 Hz, Cα), 121.2 (d, 3JCP
8
4
As for 7a starting from 5b (0.050 g, 0.091 mmol). 31P{1H} NMR
3
3
(161.8 MHz, CD2Cl2): δ 79.1 (s). 1H NMR (399.8 MHz,
Hz, C9), 120.2 (s, C5), 116.4 (d, JCP 9 Hz, Cβ), 112.5 (d, JCP
Hz, C3), 0.6 (s, Me). 19F{1H} NMR (376.2 MHz, CD2Cl2):
3
3
CD2Cl2): δ 8.37 (bd, 1H, JHH 5.2 Hz, H6), 8.11 (dm, 1H, JHH
8.0 Hz, H4), 7.42 (ps. t, 1H, 3JHH 3.5 Hz, 3JHP 3.5 Hz, H2), 7.39
δ Ϫ78.5 (s).
3
(dd, 1H, JHH 5.2, 8.0 Hz, H5), 7.09–7.07 (m, 4H, Hα), 6.93 (d,
Synthesis of [PdCl{C(O)Me}(L1-ꢀ2P,N)] 6a
1H, 3JHH 3.5 Hz, H3), 6.57–6.55 (m, 4H, Hβ), 2.18 (d, 3H, 4JHP
3.2 Hz, Me). 13C{1H} NMR (100.5 MHz, CD2Cl2): δ 216.5 (d,
2JCP 12 Hz, CO), 153.3 (d, 2JCP 20 Hz, C8), 143.7 (s, C6), 133.1 (s,
C4), 125.2 (d, 2JCP 7 Hz, C2), 124.0 (d, 2JCP 10 Hz, Cα), 121.7 (d,
Compound 4a (0.078 g, 0.17 mmol) was transferred into a
NMR tube fitted with a Young valve and dissolved in a mini-
mum amount of CD2Cl2. A CO pressure of approximately 10
psi was applied and the NMR tube was shaken vigorously.
After 48 h the solution was transferred into a small Schlenk and
hexane added to precipitate a pale yellow powder. This was
isolated by filtration and dried under reduced pressure. Yield:
0.057 g (69%). Calc. for C21H18ClN2OPPdؒ1/4CH2Cl2: C, 50.2;
H, 3.67; N, 5.51%. Found: C, 50.2; H, 3.64; N, 5.51%. 31P{1H}
3
3JCP 7 Hz, C9), 120.2 (s, C5), 116.4 (d, JCP 8 Hz, Cβ), 112.0 (d,
3JCP 3 Hz, C3), 36.6 (d, 3JCP 46 Hz, Me). 19F{1H} NMR (376.2
MHz, CD2Cl2): δ Ϫ78.2 (s). IR (CD2Cl2, cmϪ1): 1729 [s, ν(CO)].
Synthesis of [Pd{CH2CH2C(O)Me-ꢀ2C,O}(L1-ꢀ2P,N)]OTf 8a
Compound 5a (0.050 g, 0.087 mmol) was transferred to a NMR
tube fitted with a Young valve and dissolved in a minimum
amount of CD2Cl2. A CO pressure of approximately 20 psi was
applied and the NMR tube was shaken vigorously. After 20 min
the NMR tube was immersed in liquid nitrogen and placed
under reduced pressure. After 10 min the Young valve was
closed and the NMR tube was left to reach ambient temper-
ature. This operation was repeated three times in order to elim-
inate unreacted CO. A C2H4 pressure of approximately 10 psi
was applied and the NMR tube was shaken vigorously every
10 min for 1 h. After this time the 31P{1H} NMR spectrum
1
NMR (161.8 MHz, CDCl3): δ 64.9 (s). H NMR (399.8 MHz,
3
3
CDCl3): δ 8.68 (d, 1H, JHH 5.2 Hz, H6), 8.04 (d, 1H, JHH
7.8 Hz, H4), 7.71–7.66 (m, 4H, Hm), 7.61–7.58 (m, 2H, Hp),
7.55–7.50 (m, 4H, Ho), 7.28 (dd, 1H, 3JHH 5.2, 7.8 Hz, H5), 7.17
(dd, 1H, 3JHH 3.6 Hz, 3JHP 2.4 Hz, H2), 6.82 (d, 1H, 3JHH 3.6 Hz,
H3), 2.34 (s, 3H, Me). 13C{1H} NMR (100.5 MHz, CD2Cl2):
2
2
δ 224.3 (d, JCP 6 Hz, CO), 154.8 (d, JCP 21 Hz, C8), 143.2 (s,
C6), 133.5–130.0 (m, Ci, Co, Cm, Cp, C4), 127.0 (d, 2JCP 9 Hz, C2),
121.5 (d, 3JCP 8 Hz, C9), 119.1 (s, C5), 110.9 (s, C3), 39.0 (d, 3JCP
30 Hz, Me). IR (KBr, cmϪ1): 1697 [s, ν(CO)].
D a l t o n T r a n s . , 2 0 0 3 , 4 7 1 8 – 4 7 3 0
4727